Johansson E - Search Results

1

Seroepidemiology of selected transboundary animal diseases in goats in Zambia.

Lysholm S, Lindahl JF, Dautu G, Johansson E, Bergkvist PK, Munyeme M, Wensman JJ. Lysholm S, et al. Among authors: johansson e. Prev Vet Med. 2022 Sep;206:105708. doi: 10.1016/j.prevetmed.2022.105708. Epub 2022 Jul 8. Prev Vet Med. 2022. PMID: 35835047 Free article.

2

Interleukin 6, serum amyloid A and haptoglobin as markers of treatment efficacy in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Hultén C, Johansson E, Fossum C, Wallgren P. Hultén C, et al. Among authors: johansson e. Vet Microbiol. 2003 Aug 29;95(1-2):75-89. doi: 10.1016/s0378-1135(03)00136-6. Vet Microbiol. 2003. PMID: 12860078

3

Effects of an experimental infection with Actinobacillus pleuropneumoniae on the interferon-alpha and interleukin-6 producing capacity of porcine peripheral blood mononuclear cells stimulated with bacteria, virus or plasmid DNA.

Johansson E, Fossum C, Fuxler L, Wallgren P. Johansson E, et al. Vet Microbiol. 2001 Mar 20;79(2):171-82. doi: 10.1016/s0378-1135(00)00353-9. Vet Microbiol. 2001. PMID: 11230938

4

Characterisation of porcine monocyte-derived dendritic cells according to their cytokine profile.

Johansson E, Domeika K, Berg M, Alm GV, Fossum C. Johansson E, et al. Vet Immunol Immunopathol. 2003 Feb 10;91(3-4):183-97. doi: 10.1016/s0165-2427(02)00310-0. Vet Immunol Immunopathol. 2003. PMID: 12586481

5

The plasmid pcDNA3 differentially induces production of interferon-alpha and interleukin-6 in cultures of porcine leukocytes.

Magnusson M, Johansson E, Berg M, Eloranta ML, Fuxler L, Fossum C. Magnusson M, et al. Among authors: johansson e. Vet Immunol Immunopathol. 2001 Jan 10;78(1):45-56. doi: 10.1016/s0165-2427(00)00251-8. Vet Immunol Immunopathol. 2001. PMID: 11182147

6

The DNA vaccine vector pcDNA3 induces IFN-alpha production in pigs.

Johansson E, Wallgren P, Fuxler L, Domeika K, Lefèvre F, Fossum C. Johansson E, et al. Vet Immunol Immunopathol. 2002 Aug;87(1-2):29-40. doi: 10.1016/s0165-2427(02)00024-7. Vet Immunol Immunopathol. 2002. PMID: 12052340

7

How to strengthen the RTW process and collaboration between patients with chronic pain and their employers in interdisciplinary pain rehabilitation programs? Patients' experiences of the Demand and Ability Protocol.

Johansson E, Svartengren M, Danielsson K, Hellman T. Johansson E, et al. Disabil Rehabil. 2023 Jun;45(12):2013-2020. doi: 10.1080/09638288.2022.2083246. Epub 2022 Jun 10. Disabil Rehabil. 2023. PMID: 35687518

8

Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry.

Johansson E, Norén K, Sjövall J, Halldin MM. Johansson E, et al. Biomed Chromatogr. 1989 Jan;3(1):35-8. doi: 10.1002/bmc.1130030109. Biomed Chromatogr. 1989. PMID: 2539872

9

Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.

Johansson E, Halldin MM, Agurell S, Hollister LE, Gillespie HK. Johansson E, et al. Eur J Clin Pharmacol. 1989;37(3):273-7. doi: 10.1007/BF00679783. Eur J Clin Pharmacol. 1989. PMID: 2558889

10

Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.

Johansson E, Halldin MM. Johansson E, et al. J Anal Toxicol. 1989 Jul-Aug;13(4):218-23. doi: 10.1093/jat/13.4.218. J Anal Toxicol. 1989. PMID: 2550702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,438 results

Search Page

Filters